A multicenter, controlled, observational cohort study evaluated the effects of supportive mistletoe extract (Iscador) treatment in patients with nonmetastatic colorectal carcinoma undergoing adjuvant therapy. The study involved 804 patients (429 receiving Iscador and 375 controls) across 26 centers, with a median follow-up of 58 months for the Iscador group and
